文献速递湿疹皮炎与荨麻疹

整合分子证据优先排序特应性皮炎已确立位点的候选因果基因

Triangulating Molecular Evidence to Prioritize Candidate Causal Genes at Established Atopic Dermatitis Loci.
PubMed 文献 · J Invest Dermatol · 2021-04-24

该研究针对特应性皮炎GWAS已识别的25个可重复位点,整合103种分子资源(表达、蛋白、DNA甲基化数量性状位点数据集)与功能注释,构建生物信息学流程对每个位点的基因进行优先排序评分。结果显示顶级优先基因富集适应性免疫调节与表皮屏障形成功能,并在8个位点各优先出单一候选基因(IL6R、ADO、PRR5L、IL7R、ETS1、INPP5D、MDM1、TRAF3),其中6个位点优先出较少见候选(SLC22A5、IL2RA、MDM1、DEXI、ADO、STMN3)。

要点

  • 整合多组学资源可对特应性皮炎GWAS位点候选基因进行优先排序。
  • 顶级优先基因富集适应性免疫调节和表皮屏障形成功能。
  • 8个位点各优先出单一候选基因,部分为较少见候选,可能成为药物靶点。

核心结论

  • 整合分子资源与功能注释的优先排序流程支持部分已知特应性皮炎基因,并提示其他位点的额外候选基因。

研究设计与样本

  • 研究针对GWAS识别的25个可重复特应性皮炎位点,汇编103种分子资源(包括皮肤或免疫相关组织的表达、蛋白和DNA甲基化数量性状位点数据集),结合调控变异预测、启动子-增强子互作、表达研究和变异精细定位进行功能注释,并对每个位点每个基因计算优先排序评分。

主要发现

  • 在顶级优先基因中检测到具有适应性免疫调节功能和表皮屏障形成的基因显著富集。
  • 在8个位点各优先出单一候选基因:IL6R、ADO、PRR5L、IL7R、ETS1、INPP5D、MDM1、TRAF3。
  • 在25个位点中的6个位点,分析优先出较少熟悉的候选基因:SLC22A5、IL2RA、MDM1、DEXI、ADO、STMN3。

关键数值与推荐

  • 共纳入25个可重复的特应性皮炎GWAS位点。
  • 共汇编103种分子资源用于优先排序。
  • 8个位点各优先出单一候选基因,6个位点优先出较少熟悉候选基因。

临床怎么用

  • 该优先排序结果可为特应性皮炎GWAS位点的功能跟进和药物靶点发现提供候选基因列表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

GWASs for atopic dermatitis have identified 25 reproducible loci. We attempt to prioritize the candidate causal genes at these loci using extensive molecular resources compiled into a bioinformatics pipeline. We identified a list of 103 molecular resources for atopic dermatitis etiology, including expression, protein, and DNA methylation quantitative trait loci datasets in the skin or immune-relevant tissues, which were tested for overlap with GWAS signals. This was combined with functional annotation using regulatory variant prediction and features such as promoter‒enhancer interactions, expression studies, and variant fine mapping. For each gene at each locus, we condensed the evidence into a prioritization score. Across the investigated loci, we detected significant enrichment of genes with adaptive immune regulatory function and epidermal barrier formation among the top-prioritized genes. At eight loci, we were able to prioritize a single candidate gene (IL6R, ADO, PRR5L, IL7R, ETS1, INPP5D, MDM1, TRAF3). In addition, at 6 of the 25 loci, our analysis prioritizes less familiar candidates (SLC22A5, IL2RA, MDM1, DEXI, ADO, STMN3). Our analysis provides support for previously implicated genes at several atopic dermatitis GWAS loci as well as evidence for plausible additional candidates at others, which may represent potential targets for drug discovery.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Sobczyk MK, Richardson TG, Zuber V, et al. Triangulating Molecular Evidence to Prioritize Candidate Causal Genes at Established Atopic Dermatitis Loci. J Invest Dermatol. 2021. PMID: 33901562. doi:10.1016/j.jid.2021.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。